Screener
Surgery Partners, Inc. SGRY Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Surgery Partners, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Surgery Partners, Inc.’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001638833-26-000077
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Purchases of equity investments | — | (3.8) |
| Proceeds from sales of equity investments | 0.9 | — |
| Other investing activities | 7.5 | (19.3) |
| Net cash provided by (used in) investing activities | (33.2) | (74.3) |
| Cash flows from financing activities: | ||
| Principal payments on long-term debt | (310.2) | (299.4) |
| Borrowings of long-term debt | 350.0 | 382.2 |
| Payments of debt issuance costs | (0.4) | — |
Item 1. Financial Statements
FAQ
- What is Surgery Partners, Inc.'s investing cash flow?
- Surgery Partners, Inc. (SGRY) reported investing cash flow of -$19.8M in Q2 2026.
- What is the long-term trend for Surgery Partners, Inc.'s investing cash flow?
- Over 4 years (2021 to 2025), Surgery Partners, Inc.'s investing cash flow has grown at a -6.9% compound annual growth rate (CAGR), from -$331.7M to -$248.7M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Surgery Partners, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude